REPORT:’6 STATS ON HAI COSTS: Realizing the cost of hospital-acquired infections may incentivize hospitals to step-up infection control efforts, according to an article published in the Journal of the American Medical Association.
STUDY: NURSE-DIRECTED PROTOCOL REDUCES CATHETER USE 50%, CAUTIs 70%: A nurse-directed catheter removal protocol was associated with reduced urinary catheter use and lower catheter-associated urinary tract infection rates in a Connecticut hospital, according to a study in the American Journal of Infection Control. Over three years, the hospital reduced overall catheter use 50 percent and reduced CAUTIs 70 percent.
HOW TO REDUCE HAIS THROUGH EDUCATION: HHS estimates that one in 20 hospitalized patients has a hospital-acquired infection, an epidemic which is responsible for between $28 billion to $33 billion in unnecessary healthcare expenditures annually.
STATES’ PROGRESS IN REDUCING CENTRAL LINE INFECTIONS: The CLABSI rates are those reported to the Centers for Disease Control and Prevention’s National Healthcare Safety Network and listed in CMS’ Hospital Compare database. Here are the 50 states and the District of Columbia listed according to their progress in reducing central line-associated bloodstream infections based on data from July 2011 to June 2012.
CREATING AND MAINTAINING AN ACTIVE INFECTION PREVENTION PROGRAM: One of the most common deficiencies listed in Medicare, state and accreditation surveys is not having an active infection prevention/control program. Surveyors want you to be able to talk the talk of infection prevention, see how you have documented and analyzed your infection prevention activities.
WHERE DO YOU STAND WITH SAFETY SCALPELS? : Out of 124 respondents, 52% said that safety scalpels are never or rarely used at their facilities. In comparison, 17.9% said they’re the only available option and 18.7% said they’re used most of the time.
CDC MMWR ON VITALSIGNS: CARBAPENEM-RESISTANT ENTEROBACTERIACEAE SUMMARY: 2013 MMWR report reviews Enterobacteriaceae resistance to broad-spectrum carbapenem antimicrobials has been uncommon, but over the past decade, carbapenem-resistant Enterobacteriaceae (CRE) have been recognized in health-care settings as a cause of difficult-to-treat infections associated with high mortality.
CDC FEATURE REPORT- PATIENTS FACE MORE LETHAL INFECTIONS FROM CRE : A new Vitalsigns report shows that antibiotics are being overpowered by lethal germs called carbapenem-resistant Enterobacteriaceae (CRE). These germs cause lethal infections in patients receiving inpatient medical care such as in hospitals, long-term acute care facilities, and nursing homes.
2012 CRE TOOLKIT : CDC document that expands on the 2009 CDC recommendations for the Control of Carbapenem-resistant Enterobacteriaceae (CRE)